Ignite Creation Date:
2024-05-06 @ 2:27 AM
Last Modification Date:
2024-10-26 @ 11:18 AM
Study NCT ID:
NCT02040870
Status:
COMPLETED
Last Update Posted:
2019-02-20
First Post:
2014-01-17
Brief Title:
LDK378 in Adult Chinese Patients With ALK-rearranged ALK-positive Advanced Non-small Cell Lung Cancer NSCLC Previously Treated With Crizotinib
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CLDK378A2109
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None